Sugi Predict

Sugi Predict / Compounds / SCHEMBL1406541

SCHEMBL1406541

SCHEMBL1406541

CN1CCN(c2cc(C(O)C=Cc3ccc(C(=O)O)cc3)cc(C(C)(C)C)c2NCCc2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 1/20 0.39
▸ RARB P10826 1/20 0.39
▸ RARG P13631 1/20 0.39
▸ HTR6 P50406 4/20 0.38
▸ RBP4 P02753 1/20 0.37
▸ ESR2 Q92731 3/20 0.37
▸ HRH4 Q9H3N8 5/20 0.36
▸ HRH1 P35367 2/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ HDAC3 O15379 2/20 0.35
▸ HDAC4 P56524 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ HDAC7 Q8WUI4 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ HDAC10 Q969S8 2/20 0.35
▸ HDAC11 Q96DB2 2/20 0.35
▸ HDAC8 Q9BY41 2/20 0.35
▸ HDAC6 Q9UBN7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1406911 0.92 RARA (0.40) RARARARBRARGHTR6RBP4
SCHEMBL1406748 0.92 RARA (0.40) RARARARBRARGHTR6RBP4
SCHEMBL1406997 0.89 RARA (0.38) RARARARBRARGRBP4PTGER4
SCHEMBL1406551 0.87 RARA (0.39) RARARARBRARGRBP4HRH4
SCHEMBL1406360 0.87 RARA (0.39) RARARARBRARGRBP4HRH4
SCHEMBL1406861 0.85 TNFRSF1A (0.45) HTR6RBP4HDAC3HDAC4HDAC1
SCHEMBL1406938 0.82 HTR6 (0.38) HTR6RBP4ESR2HRH4HRH1
SCHEMBL1406474 0.82 MAPK1 (0.41) RARARARBRARGHTR6RBP4
SCHEMBL1406539 0.82 RARA (0.40) RARARARBRARGHTR6RBP4
SCHEMBL1406642 0.82 MAPK1 (0.41) RARARARBRARGHTR6RBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513793-B1 NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS GALDERMA RES & DEV (FR) 2011-03-09 — — EP claimed
US-20050131033-A1 Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-06-16 — — US claimed
EP-1513793-B1 NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS GALDERMA RES & DEV (FR) 2011-03-09 — — EP disclosed
US-7468457-B2 Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2008-12-23 — — US disclosed
US-20050131033-A1 Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131033-A1 Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof RARA, RARB, RARG RARA 1/4885RARB 2/4885RARG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.